OX40 and LAG3 are associated with better prognosis in advanced gastric cancer patients treated with anti-programmed death-1 antibody.
Ohmura H, Yamaguchi K, Hanamura F, Ito M, Makiyama A, Uchino K, Shimokawa H, Tamura S, Esaki T, Mitsugi K, Shibata Y, Oda H, Tsuchihashi K, Ariyama H, Kusaba H, Oda Y, Akashi K, Baba E.
Ohmura H, et al. Among authors: kusaba h.
Br J Cancer. 2020 May;122(10):1507-1517. doi: 10.1038/s41416-020-0810-1. Epub 2020 Mar 23.
Br J Cancer. 2020.
PMID: 32203221
Free PMC article.